12 May 2025 : Clinical Research
Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients
Adam StadnikDOI: 10.12659/MSM.947864
Med Sci Monit 2025; 31:e947864
Table 3 Characteristics and comparison of the subsequent assessments in terms of cognitive function in the 2 groups.
| 1st assessment | 2nd assessment | 3rd assessment | p (1st vs 2nd) | p (1st vs 3rd) | p (2nd vs 3rd) | |
|---|---|---|---|---|---|---|
| Median [IQR](min.–max.) or n (%) | Median [IQR](min.–max.) or n (%) | Median [IQR](min.–max.) or n (%) | ||||
| Study group [n=28]# | ||||||
| MoCA | 24 [–](19–28)22 | 24 [–](19–28)22 | 25 [–](22–30)24 | 0.8321 | 0.1162 | 0.0773 |
| Control [n=24]# | ||||||
| MoCA | 25.5 [–](22–29)23 | 27 [–](2–29)24 | 27 [–](5–30)25 | 0.2954 | 0.1209 | 0.4753 |
| MoCA – Montreal Cognitive Assessment; # The number of cases is lower due to pairwise comparisons. | ||||||






